ClinicalTrials.gg

AbbVie clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 2,251 studies whose lead sponsor is AbbVie or one of 25 companies grouped under it. 133 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 17, 2026.

Our grouping of 27 registry names, not the registry’s. See them and correct one ↓

Compare AbbVie with Johnson & Johnson and Bristol-Myers Squibb →

Pipeline: 70 programs

Each counted once: 61 with a study AbbVie leads registered in the last two years, 9 more from AbbVie's own pipeline.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)
  • Named by AbbVie only (no registered study yet; not in the 70)

The 5 of 16 with the most live studies.

Program
telisotuzumab adizutecanPhase 3 · AbbVie: Phase 3 · 17 live · Colorectal Neoplasms · primary completion Dec 2026☆ Track
etentamigPhase 3 · AbbVie: Registration · 11 live · Multiple Myeloma · primary completion Feb 2027☆ Track
lutikizumabPhase 3 · AbbVie: Phase 3 · 8 live · Hidradenitis Suppurativa · primary completion Dec 2026☆ Track
mirvetuximab soravtansinePhase 3 · 5 live · Carcinoma, Ovarian Epithelial · primary completion Nov 2026☆ Track
turmetabart adizutecanPhase 3 · AbbVie: Phase 3 · 5 live · Small Cell Lung Carcinoma · primary completion Nov 2027☆ Track

11 more in phase 3 — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of AbbVie’s own registered studies; “AbbVie says” is its pipeline, which lists phases by indication. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs AbbVie’s studies test, most open studies first — 279 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 279; every drug is on its own page, and each page lists its sponsors.

Coming up

90 of AbbVie’s studies under way reach primary completion within a year, 18 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 9N’26
  2. 8D
  3. 7J’27
  4. 13F
  5. 9M
  6. 5A
  7. 8M
  8. 4J
  9. 7J
  10. 5A
  11. 6S
  12. 2O
  13. 7N

The 12 nearest

Show 7 more

Add all 90 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 18, 2026.

Newly registered11

Show 6 more

All 2,251 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1336%Recruiting 113 · Not yet recruiting 15 · Enrolling by invitation 5
  • Under way, not recruiting1145%
  • Completed1,72377%
  • Stopped early26112%Terminated 207 · Withdrawn 53 · Suspended 1
  • Status unknown or other201%No longer available 12 · Available 4 · Status unknown 2 · Approved for marketing 1 · Temporarily not available 1

Phase

Where

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 14612
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 7326

By the year each study started; 178 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to AbbVie.

  • AbbVie
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    977 studies
  • Allergan
    Acquired — became part of AbbVie, May 8, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    505 studies →
  • AbbVie (prior sponsor, Abbott)
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    223 studies
  • Forest Laboratories
    Acquired — became part of AbbVie, May 8, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    168 studies →
  • Warner Chilcott
    Acquired — became part of AbbVie, May 8, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    58 studies →
  • Repros Therapeutics Inc.
    Acquired — became part of AbbVie, May 8, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    58 studies →
  • Pharmacyclics LLC.
    Acquired — became part of AbbVie, May 26, 2015 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    54 studies →
  • Zeltiq Aesthetics
    Acquired — became part of AbbVie, May 8, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    39 studies →
  • Watson Pharmaceuticals
    Acquired — became part of AbbVie, May 8, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    30 studies →
  • Kythera Biopharmaceuticals
    Acquired — became part of AbbVie, May 8, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    23 studies →
  • Cerevel Therapeutics, LLC
    Acquired — became part of AbbVie, Aug 1, 2024 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    22 studies →
  • Naurex, Inc, an affiliate of Allergan plc
    Acquired — became part of AbbVie, May 8, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    20 studies →
  • ImmunoGen, Inc.
    Acquired — became part of AbbVie, Feb 12, 2024 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    16 studies →
  • Tobira Therapeutics, Inc.
    Acquired — became part of AbbVie, May 8, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    12 studies →
  • Allergan Medical
    Acquired — became part of AbbVie, May 8, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    11 studies →
  • Durata Therapeutics Inc., an affiliate of Allergan plc
    Acquired — became part of AbbVie, May 8, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies →
  • Furiex Pharmaceuticals, Inc
    Acquired — became part of AbbVie, May 8, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies →
  • Stemcentrx
    Acquired — became part of AbbVie, Jun 1, 2016 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • Chase Pharmaceuticals Corporation, an affiliate of Allergan plc
    Acquired — became part of AbbVie, May 8, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • Apogee Therapeutics, Inc.
    Acquired — became part of AbbVie, Sep 3, 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • Syndesi Therapeutics
    Acquired — became part of AbbVie, Mar 1, 2022 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Landos Biopharma Inc.
    Acquired — became part of AbbVie, May 23, 2024 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Pharmacyclics Switzerland GmbH
    Acquired — became part of AbbVie, May 26, 2015 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Vitae Pharmaceuticals Inc., an Allergan affiliate
    Acquired — became part of AbbVie, May 8, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Celsius Therapeutics, Inc.
    Acquired — became part of AbbVie, Jun 27, 2024 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Capstan Therapeutics
    Acquired — became part of AbbVie, Aug 19, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Allergan S.A. DE C.V..
    Acquired — became part of AbbVie, May 8, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions AbbVie leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Show all 65 areas

Studies

Recruiting first, then most recently updated. Showing 50 of 2,251. Browse all 2,251 →